paxilline has been researched along with Hepatitis C in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alisi, A; Arciello, M; Balsano, C; Conti, B; Missale, G; Petrini, S | 1 |
1 other study(ies) available for paxilline and Hepatitis C
Article | Year |
---|---|
Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.
Topics: Actinin; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Focal Adhesion Protein-Tyrosine Kinases; Hepacivirus; Hepatic Stellate Cells; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Paxillin; Tumor Necrosis Factor-alpha | 2012 |